Craig A. Tooman
2016 - Aratana Therapeutics
In 2016, Craig A. Tooman earned a total compensation of $707.2K as Chief Financial Officer at Aratana Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $114,800 |
|---|---|
| Option Awards | $121,131 |
| Salary | $350,000 |
| Stock Awards | $110,685 |
| Other | $10,600 |
| Total | $707,216 |
Tooman received $350K in salary, accounting for 49% of the total pay in 2016.
Tooman also received $114.8K in non-equity incentive plan, $121.1K in option awards, $110.7K in stock awards and $10.6K in other compensation.
Rankings
In 2016, Craig A. Tooman's compensation ranked 9,828th out of 14,075 executives tracked by ExecPay. In other words, Tooman earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,828 out of 14,075 | 30th |
Division Manufacturing | 3,797 out of 5,489 | 31st |
Major group Chemicals And Allied Products | 1,327 out of 1,895 | 30th |
Industry group Drugs | 1,056 out of 1,538 | 31st |
Industry Pharmaceutical Preparations | 829 out of 1,176 | 30th |
Source: SEC filing on June 8, 2018.
Tooman's colleagues
We found three more compensation records of executives who worked with Craig A. Tooman at Aratana Therapeutics in 2016.